Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock

BackgroundKounis syndrome is a hypersensitive coronary artery disease caused by the body's exposure to allergens, which is induced by various drugs and environmental factors. This entity has been described primarily in isolated case reports and case series. We report a case of type III Kounis s...

Full description

Bibliographic Details
Main Authors: Peng Ding, Yuan Zhou, Kun-lan Long, Li Zhang, Pei-yang Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061586/full
_version_ 1811313856712015872
author Peng Ding
Yuan Zhou
Kun-lan Long
Li Zhang
Pei-yang Gao
author_facet Peng Ding
Yuan Zhou
Kun-lan Long
Li Zhang
Pei-yang Gao
author_sort Peng Ding
collection DOAJ
description BackgroundKounis syndrome is a hypersensitive coronary artery disease caused by the body's exposure to allergens, which is induced by various drugs and environmental factors. This entity has been described primarily in isolated case reports and case series. We report a case of type III Kounis syndrome caused by cefoperazone-sulbactam.Case presentationA 79-year-old man who received an infusion of cefoperazone-sulbactam in Respiratory Department of our hospital for recurrent infections. 28 minutes later, he developed skin flushing of the trunk and extremities, soon followed by loss of consciousness and shock. With antianaphylaxis, pressor therapy, and fluid rehydration, the patient was admitted to the ICU for treatment. During which, he experienced recurrent ventricular fibrillation and a progressive increase in troponin I levels. The ECG of the patient showed that the ST segment elevation of lead II, III, avF, and V3R–V5R was 0.10–0.20 MV. An urgent coronary angiography showed an in-stent thrombosis in the middle part of the right coronary artery, occlusion of the distal flow with TIMI grade 0. The diagnosis was type III Kounis syndrome with cardiogenic shock. Despite aggressive treatment, the patient died on day 7 after ICU admission.ConclusionKunis syndrome is a life-threatening disease, and therefore allergic reactions in patients with a history of cephalosporin allergy and coronary stent implantation should be considered and treated promptly.
first_indexed 2024-04-13T11:02:02Z
format Article
id doaj.art-5fea8a918e5d4fc6acd2c996e0ce7ff1
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T11:02:02Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-5fea8a918e5d4fc6acd2c996e0ce7ff12022-12-22T02:49:22ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10615861061586Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shockPeng Ding0Yuan Zhou1Kun-lan Long2Li Zhang3Pei-yang Gao4Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Geriatric Medicine, General Hospital of Western Theater Command, PLA, Chengdu, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Cardiology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaBackgroundKounis syndrome is a hypersensitive coronary artery disease caused by the body's exposure to allergens, which is induced by various drugs and environmental factors. This entity has been described primarily in isolated case reports and case series. We report a case of type III Kounis syndrome caused by cefoperazone-sulbactam.Case presentationA 79-year-old man who received an infusion of cefoperazone-sulbactam in Respiratory Department of our hospital for recurrent infections. 28 minutes later, he developed skin flushing of the trunk and extremities, soon followed by loss of consciousness and shock. With antianaphylaxis, pressor therapy, and fluid rehydration, the patient was admitted to the ICU for treatment. During which, he experienced recurrent ventricular fibrillation and a progressive increase in troponin I levels. The ECG of the patient showed that the ST segment elevation of lead II, III, avF, and V3R–V5R was 0.10–0.20 MV. An urgent coronary angiography showed an in-stent thrombosis in the middle part of the right coronary artery, occlusion of the distal flow with TIMI grade 0. The diagnosis was type III Kounis syndrome with cardiogenic shock. Despite aggressive treatment, the patient died on day 7 after ICU admission.ConclusionKunis syndrome is a life-threatening disease, and therefore allergic reactions in patients with a history of cephalosporin allergy and coronary stent implantation should be considered and treated promptly.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061586/fullKounis syndromecefoperazone-sulbactamcardiogenic shockallergyintra-stent thrombosiscase report
spellingShingle Peng Ding
Yuan Zhou
Kun-lan Long
Li Zhang
Pei-yang Gao
Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
Frontiers in Cardiovascular Medicine
Kounis syndrome
cefoperazone-sulbactam
cardiogenic shock
allergy
intra-stent thrombosis
case report
title Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
title_full Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
title_fullStr Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
title_full_unstemmed Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
title_short Case report: Cefoperazone-sulbactam induced Kounis syndrome and cardiogenic shock
title_sort case report cefoperazone sulbactam induced kounis syndrome and cardiogenic shock
topic Kounis syndrome
cefoperazone-sulbactam
cardiogenic shock
allergy
intra-stent thrombosis
case report
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061586/full
work_keys_str_mv AT pengding casereportcefoperazonesulbactaminducedkounissyndromeandcardiogenicshock
AT yuanzhou casereportcefoperazonesulbactaminducedkounissyndromeandcardiogenicshock
AT kunlanlong casereportcefoperazonesulbactaminducedkounissyndromeandcardiogenicshock
AT lizhang casereportcefoperazonesulbactaminducedkounissyndromeandcardiogenicshock
AT peiyanggao casereportcefoperazonesulbactaminducedkounissyndromeandcardiogenicshock